BRD2 and Osteopenia: In general, HRT was thought to be an important option for improving BMD in TS osteopenia or osteoporotic women because estrogen-deficiency and elevated follicle stimulating hormone (FSH) levels are two of the major reasons for bone loss in TS individuals (4, 23).